Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages

Stefano Soldano(University of Genoa), Maurizio Cutolo(Ospedale Policlinico San Martino)

PLoS ONE

November 15, 2016

10.1371/journal.pone.0166433

Cited by 68

Related Papers

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

|Annals of the Rheumatic Diseases|2016|331

European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

|Journal of the European Academy of Dermatology and Venereology|2017|261

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)

|Endocrine|2017|68

CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients

|Arthritis Research & Therapy|2021|42

Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease

|Frontiers in Immunology|2024|11